Saran - KESIMPULAN DAN SARAN - Yenny K G G2A008198 Lap

BAB VII KESIMPULAN DAN SARAN

7.2 Saran

1. Kelengkapan lampiran hasil USG dan hasil biopsi PA pada catatan medik perlu ditingkatkan karena sering tidak ditemukan walaupun pada catatan medik tertulis bahwa tindakan tersebut telah dilakukan.

2. Perlu dibuat format temuan baku laporan hasil USG untuk menilai kelainan pada kelenjar tiroid yang dapat mengarah kepada keganasan.

DAFTAR PUSTAKA

1. RI LD. Data Kanker diIndonesia Berdasar Pathologic Based. Jakarta2003. 2. SI S. Thyroid Carcinoma. Lancet2003. p 501-11.

3. Lewinski F, Jarzab. Thyroid Carcinoma: Diagnostic and Therapeutic Approach; genetic background, endocrine regulation. 2000; 34 : 99-113. 4. Vander JB GE, Cawber TR. The Significance of Nontoxic Thyroid Nodule.

Ann Intern Med. 1988;69:537-40.

5. Tumbridge WMG ED, Hall R, et. al. The spectrum of Thyroid Disease in a Community: the Whickham Survey. 1997;7:481-93.

6. Gharib H PE, Valcaci R, Baskin HJ, Crescenzi A, Dottorini ME, et al. American Association of Clinical Endocrinologists and Associazione Medici Endocrinologi medical guidelines for clinical practice for the diagnosis and management of thyroid nodules. Endocr Pract. 2006;12:63-102.

7. Fukunari N NM, Sugino K, Mimura T, Ito K. Clinical evaluation of color Doppler imaging for the differential diagnosis of thyroid follicular lessions. World J Surg. 2004;28:1261-5.

8. Chammas MC GR, de Olieviria IR, WidmanA, de Barros N, Durazzo M, et al. Thyroid Nodules: evaluation with power Doppler and dupplex Doppler Ultrasound. Otolaryngol Head Neck Surgery. 2005;132:874-82.

9. Parkin D. M. Whelan S. l. FJ. Cancer Incidence en five Continents. International Agency for Research on Cancer. 1997;7.

10. Subekti I. Karsinoma Tiroid. In: Aru W. Sudoyo BS, Idrus Alwi, Marcellinus Simadibrata, Siti Setiati, editor. Buku Ajar Ilmu Penyakit Dalam. 5 ed. Jakarta: Interna Publishing; 2010. p. 2031-37.

11. Martin Schlumberger FP. Thyroid Tumors. Paris: Nucleon; 2006.p 111-345. 12. Tan WJ SK, Liau KH, Low CH. An audit study of the sensitivity and

specificity of ultrasound, fine needle aspiration cytology and frozen section in the evaluation of thyroid malignancies in a tertiary institution. Ann Acad Med Singapore. 2010;39(5):359-62.

13. Frederico FR Maia PSM, Bradley P Silva, Ana T Pallone, Elizabeth J Pavin, Jose Vassallo, Denise E Zantut-Wittman. Role of ultrasound, clinical and scintigraphyc parameters to predict malignancy in thyroid nodule. 2011;3:17-21.

14. Sarah Parengi RP. Thyroid Disease. California: Greenwood; 2011. p 92-4. 15. Nadia Khati TA, Karen S. Johnson, Michael C Hill. Ultrasound of the

Thyroid and Parathyroid Glands. 2003;19(4):162-76.

16. Rosenthal MS. The Thyroid Sourcebook. United States: McGraw Hill; 2009 [cited 2011 Nov 22].

17. Grangier A. Diagnostic Radiology. A. A, editor. Philadelphia: Churchill Livingstone Elseiver; 2008. p. 324-46.

18. Cooper DS DG, Haugen BR, Kloos RT, Lee SL, et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. 2009;19:1167-214.

19. Alexander EK HS, Heering JP, Benson CB, Frates MC, Doubilet PM, et al. . Natural history of benign solid and cystic thyroid nodules. Ann Intern Med. 2003;138:315–8.

20. Watters DA AA, Evans RM, Chick W, King WW, Metreweli C, et al. Role of ultrasound in the management of thyroid nodules. Am J Surg. 1992;164:654– 7.

21. Lee MJ KE, Kwak JY, Kim MJ. Partially cystic thyroid nodules on ultrasound: probability of malignancy and sonographic differentiation. 2009;19:341-6.

22. Chan BK DT, McDougall IR, Weigel RJ, Jeffrey RB Common and uncommon sonographic features of papillary thyroid carcinoma. J Ultrasound Med. 2003;22:1083–90.

23. Hatabu H KK, Yamamoto K, Iida Y, Misaki T, Hidaka A, et al. Cystic papillary carcinoma of the thyroid gland: a new sonographic sign. 1991;43:121-4.

24. Moon WJ JS, Lee JH, Na DG, Baek JH, Lee YH, et al. Benign and malignant thyroid nodules: US differentiation--multicenter retrospective study. 2008;247:762-70.

25. Bonavita JA MJ, Babb J, Bennett G, Oweity T, Macari M, et al. Pattern recognition of benign nodules at ultrasound of the thyroid: which nodules can be left alone? 2009;193:207-13.

26. Kim EK PC, Chung WY, Oh KK, Kim DI, Lee JT, et al. New sonographic criteria for recommending fine-needle aspiration biopsy of nonpalpable solid nodules of the thyroid. AJR Am J Roentgenol. 2002;178:687-91.

27. Alexander EK HS, Heering JP, Benson CB, Frates MC, Doubilet PM, et al. Thyroid nodule shape and prediction of malignancy. 2004;14:953-8.

28. Stavros AT TD, Rapp CL, Dennis MA, Parker SH, Sisney GA. Solid breast nodules: use of sonography to distinguish between benign and malignant lesions. . 1995;196:123-34.

29. Won-Jin Moon M, Jung Hwan Baek, MD,So Lyung Jung, MD, Dong Wook Kim, MD, Eun Kyung Kim, MD, Ji Young Kim, MD, Jin Young Kwak, MD, Jeong Hyun Lee, MD, Joon Hyung Lee, MD, Young Hen Lee, MD, Dong Gyu Na, MD, Jeong Seon Park, MD,Sun Won Park, MD. Ultrasonography and the Ultrasound-Based Management of Thyroid Nodules: Consensus Statement and Recommendations. 2011;12(1):1-14.

30. Papini E GR, Bianchini A, Crescenzi A, Taccogna S, Nardi F, et al. Risk of malignancy in nonpalpable thyroid nodules: predictive value of ultrasound and color-Doppler features. 2002;87:1941-6.

31. Khoo ML AS, Witterick IJ, Freeman JL. Thyroid calcification and its association with thyroid carcinoma. 2002;24:651-5.

32. Peccin S dCJ, Furlanetto TW, Furtado AP, Brasil BA, Czepielewski MA. Ultrasonography: is it useful in the diagnosis of cancer in thyroid nodules? 2002;25:39-43.

33. Kwak MS BJ, Kim YS, Jeong HJ. Patterns and significance of peripheral calcifications of thyroid tumors seen on ultrasound. 2005;53:401-5.

34. Yoon DY LJ, Chang SK, Choi CS, Yun EJ, Seo YL, et al. Peripheral calcification in thyroid nodules: ultrasonographic features and prediction of malignancy. 2007;26:1349-55.

35. Kim BM KM, Kim EK, Kwak JY, Hong SW, Son EJ, et al. Sonographic differentiation of thyroid nodules with eggshell calcifications. 2008;27:1425-30.

36. Tamsel S DG, Erdogan M, Nart D, Karadeniz M, Uluer H, et al. Power Doppler US patterns of vascularity and spectral Doppler US parameters in predicting malignancy in thyroid nodules. 2007;62:245-51.

37. Moon HJ KJ, Kim MJ, Son EJ, Kim EK. Can vascularity at power Doppler US help predict thyroid malignancy. 2010;255:260-9.

38. Lyshchik A HT, Asato R, Tanaka S, Ito J, Mai JJ, et al. Thyroid gland tumor diagnosis at US elastography. . 2005;237:202-11.

39. Pramod K Sharma M. Thyroid Cancer. WebMD LLC; 2011 [updated Jun 1,

2011; cited 2012 Jan 20]; Available from:

http://emedicine.medscape.com/article/851968.

40. Center CUM. Department of Surgery : Thyroid. New York2007 [cited 2012 Jan 26]; Available from:

http://cpmcnet.columbia.edu/dept/thyroid/medcare.html.

41. Santacroce L. Follicular Thyroid Carcinoma. Italy2012; Available from: http://emedicine.medscape.com/article/278488-overview.

42. Yunus M, Ahmed Z. Significance of ultrasound features in predicting malignant solid thyroid nodules: Need for fine-needle aspiration. Journal of Pakistan Medical Assocation. 2010; 60(10): 848-53.

GET

FILE='C:\Users\Testing\Documents\KTI yenny\KTI yenny.sav'. DATASET NAME DataSet0 WINDOW=FRONT.

CROSSTABS

/TABLES=Hasil_USG Ukuran kapsul Parenkim_tiroid Komponen_nodul Ekogenisitas Kalsifikasi Peningkatan_ vaskularisasi BY Hasil_biopsi_PA

Crosstabs

[DataSet1] C:\Users\Testing\Documents\KTI yenny\KTI yenny.sav

Case Processing Summary

Cases

Valid Missing Total

N Percent N Percent N Percent

Hasil_USG * Hasil_biopsi_PA 58 72.5% 22 27.5% 80 100.0% Ukuran * Hasil_biopsi_PA 66 82.5% 14 17.5% 80 100.0% kapsul * Hasil_biopsi_PA 55 68.8% 25 31.2% 80 100.0% Parenkim_tiroid * Hasil_biopsi_PA ³⁹ ^48.8% ⁴¹ ^51.2% ⁸⁰ ^100.0% Komponen_nodul * Hasil_biopsi_PA ³¹ ^38.8% ⁴⁹ ^61.2% ⁸⁰ ^100.0% Ekogenisitas * Hasil_biopsi_PA ⁴⁸ ^60.0% ³² ^40.0% ⁸⁰ ^100.0% Kalsifikasi * Hasil_biopsi_PA 66 82.5% 14 17.5% 80 100.0% Peningkatan_vaskularisasi * Hasil_biopsi_PA ⁶⁵ ^81.2% ¹⁵ ^18.8% ⁸⁰ ^100.0%

Hasil_USG * Hasil_biopsi_PA

Crosstab

Hasil_biopsi_PA

Total Karsinoma Non karsinoma

Hasil_USG Karsinoma tiroid Count 15 4 19

% within Hasil_biopsi_PA 51.7% 13.8% 32.8%

% of Total 25.9% 6.9% 32.8%

Non Karsinoma Count 14 25 39

% within Hasil_biopsi_PA 48.3% 86.2% 67.2% % of Total 24.1% 43.1% 67.2% Total Count 29 29 58 % within Hasil_biopsi_PA 100.0% 100.0% 100.0% % of Total 50.0% 50.0% 100.0% Chi-Square Tests Value df Asymp. Sig. (2-sided) Exact Sig. (2-sided) Exact Sig. (1-sided) Pearson Chi-Square _9.471a 1 .002 Continuity Correction^b _7.827 ₁ _.005 Likelihood Ratio _9.928 ₁ _.002

Fisher's Exact Test _.004 _.002

Linear-by-Linear Association _9.308 ₁ _.002

N of Valid Cases^b ₅₈

a. 0 cells (,0%) have expected count less than 5. The minimum expected count is 9,50.

Risk Estimate

Value

95% Confidence Interval

Lower Upper

Odds Ratio for Hasil_USG (Karsinoma tiroid / Non Karsinoma)

6.696 1.857 24.142

For cohort Hasil_biopsi_PA =

Karsinoma ^2.199 ^1.362 ^3.552

For cohort Hasil_biopsi_PA =

Non karsinoma ^.328 ^.133 ^.809 N of Valid Cases ₅₈ Ukuran * Hasil_biopsi_PA Crosstab Hasil_biopsi_PA Total Karsinoma Non karsinoma

Ukuran membesar Count 19 25 44

% within Hasil_biopsi_PA 54.3% 80.6% 66.7%

% of Total 28.8% 37.9% 66.7%

tidak membesar Count 16 6 22

% within Hasil_biopsi_PA 45.7% 19.4% 33.3%

% of Total 24.2% 9.1% 33.3%

Total Count 35 31 66

% within Hasil_biopsi_PA 100.0% 100.0% 100.0%

61 Chi-Square Tests Value df Asymp. Sig. (2-sided) Exact Sig. (2-sided) Exact Sig. (1-sided) Pearson Chi-Square _5.140a 1 .023 Continuity Correction^b _4.022 ₁ _.045 Likelihood Ratio _5.295 ₁ _.021

Fisher's Exact Test _.036 _.022

Linear-by-Linear Association _5.062 ₁ _.024

N of Valid Cases^b ₆₆

a. 0 cells (,0%) have expected count less than 5. The minimum expected count is 10,33.

b. Computed only for a 2x2 table

Risk Estimate

Value

95% Confidence Interval

Lower Upper

Odds Ratio for Ukuran

(membesar / tidak membesar) ^.285 ^.094 ^.866

For cohort Hasil_biopsi_PA =

Karsinoma ^.594 ^.388 ^.908

For cohort Hasil_biopsi_PA =

Non karsinoma ^2.083 ^1.005 ^4.320

kapsul * Hasil_biopsi_PA

Crosstab

Hasil_biopsi_PA

Total Karsinoma Non karsinoma

kapsul tidak utuh Count 3 0 3

% within Hasil_biopsi_PA 10.3% .0% 5.5% % of Total 5.5% .0% 5.5% utuh Count 26 26 52 % within Hasil_biopsi_PA 89.7% 100.0% 94.5% % of Total 47.3% 47.3% 94.5% Total Count 29 26 55 % within Hasil_biopsi_PA 100.0% 100.0% 100.0% % of Total 52.7% 47.3% 100.0% Chi-Square Tests Value df Asymp. Sig. (2-sided) Exact Sig. (2-sided) Exact Sig. (1-sided) Pearson Chi-Square _2.845a 1 .092 Continuity Correction^b _1.192 ₁ _.275 Likelihood Ratio _3.995 ₁ _.046

Fisher's Exact Test _.238 _.139

Linear-by-Linear Association _2.793 ₁ _.095

N of Valid Cases^b ₅₅

a. 2 cells (50,0%) have expected count less than 5. The minimum expected count is 1,42.

Parenkim_tiroid * Hasil_biopsi_PA

Crosstab

Hasil_biopsi_PA

Total

Karsinoma Non karsinoma

Parenkim_tiroid inhomogen Count 14 15 29

% within Hasil_biopsi_PA 63.6% 88.2% 74.4% % of Total 35.9% 38.5% 74.4% homogen Count 8 2 10 % within Hasil_biopsi_PA 36.4% 11.8% 25.6% % of Total 20.5% 5.1% 25.6% Total Count 22 17 39 % within Hasil_biopsi_PA 100.0% 100.0% 100.0% % of Total 56.4% 43.6% 100.0% Risk Estimate Value 95% Confidence Interval Lower Upper

For cohort Hasil_biopsi_PA =

Karsinoma ^2.000 ^1.524 ^2.625

64 Chi-Square Tests Value df Asymp. Sig. (2-sided) Exact Sig. (2-sided) Exact Sig. (1-sided) Pearson Chi-Square 3.043a 1 .081 Continuity Correctionb 1.890 1 .169 Likelihood Ratio 3.247 1 .072

Fisher's Exact Test .140 .083

Linear-by-Linear Association 2.965 1 .085

N of Valid Casesb 39

a. 1 cells (25,0%) have expected count less than 5. The minimum expected count is 4,36.

b. Computed only for a 2x2 table

Risk Estimate

Value

95% Confidence Interval

Lower Upper

Odds Ratio for

Parenkim_tiroid (inhomogen / homogen)

.233 .042 1.293

For cohort Hasil_biopsi_PA =

Karsinoma ^.603 ^.370 ^.983

For cohort Hasil_biopsi_PA =

Non karsinoma ^2.586 ^.713 ^9.381

Komponen_nodul * Hasil_biopsi_PA

Crosstab

Hasil_biopsi_PA

Total Karsinoma Non karsinoma

Komponen_nodul Padat Count 4 4 8

% within Hasil_biopsi_PA 28.6% 23.5% 25.8% % of Total 12.9% 12.9% 25.8% kistik Count 9 11 20 % within Hasil_biopsi_PA 64.3% 64.7% 64.5% % of Total 29.0% 35.5% 64.5% kistk dan padat Count 1 2 3 % within Hasil_biopsi_PA 7.1% 11.8% 9.7% % of Total 3.2% 6.5% 9.7% Total Count 14 17 31 % within Hasil_biopsi_PA 100.0% 100.0% 100.0% % of Total 45.2% 54.8% 100.0% Chi-Square Tests Value df Asymp. Sig. (2-sided) Pearson Chi-Square .245^a 2 .885 Likelihood Ratio .249 2 .883 Linear-by-Linear Association .211 1 .646 N of Valid Cases ₃₁

a. 4 cells (66,7%) have expected count less than 5. The minimum expected count is 1,35.

Risk Estimate

Value

Odds Ratio for

Komponen_nodul (Padat / kistik)

a. Risk Estimate statistics cannot be computed. They are only computed for a 2*2 table without empty cells.

Ekogenisitas * Hasil_biopsi_PA Crosstab Hasil_biopsi_PA Total Karsinoma Non karsinoma

Ekogenisitas hipoekoik Count 10 8 18

% within Hasil_biopsi_PA 40.0% 34.8% 37.5% % of Total 20.8% 16.7% 37.5% hipereokik Count 6 2 8 % within Hasil_biopsi_PA 24.0% 8.7% 16.7% % of Total 12.5% 4.2% 16.7% Anekoik Count 4 1 5 % within Hasil_biopsi_PA 16.0% 4.3% 10.4% % of Total 8.3% 2.1% 10.4% hipoekok dan hiperekoik Count 1 5 6 % within Hasil_biopsi_PA 4.0% 21.7% 12.5% % of Total 2.1% 10.4% 12.5%

67 isoekoik dan hipoekoik Count 2 4 6 % within Hasil_biopsi_PA 8.0% 17.4% 12.5% % of Total 4.2% 8.3% 12.5% isoekoik Count 1 2 3 % within Hasil_biopsi_PA 4.0% 8.7% 6.2% % of Total 2.1% 4.2% 6.2% hiperekoik dan isoekoik Count 1 1 2 % within Hasil_biopsi_PA 4.0% 4.3% 4.2% % of Total 2.1% 2.1% 4.2% Total Count 25 23 48 % within Hasil_biopsi_PA 100.0% 100.0% 100.0% % of Total 52.1% 47.9% 100.0% Chi-Square Tests Value df Asymp. Sig. (2-sided) Pearson Chi-Square 7.619^a 6 .267 Likelihood Ratio 8.090 6 .232 Linear-by-Linear Association 2.034 1 .154 N of Valid Cases ₄₈

a. 12 cells (85,7%) have expected count less than 5. The minimum expected count is ,96.

Risk Estimate

Value

Odds Ratio for Ekogenisitas (hipoekoik / hipereokik)

a. Risk Estimate statistics cannot be computed. They are only computed for a 2*2 table without empty cells.

Kalsifikasi * Hasil_biopsi_PA

Crosstab

Hasil_biopsi_PA

Total Karsinoma Non karsinoma

Kalsifikasi ada kalsifikasi Count 19 12 31

% within Hasil_biopsi_PA 55.9% 37.5% 47.0%

% of Total 28.8% 18.2% 47.0%

tidak ada kalsifikasi Count 15 20 35

% within Hasil_biopsi_PA 44.1% 62.5% 53.0% % of Total 22.7% 30.3% 53.0% Total Count 34 32 66 % within Hasil_biopsi_PA 100.0% 100.0% 100.0% % of Total 51.5% 48.5% 100.0% Chi-Square Tests Value df Asymp. Sig. (2-sided) Exact Sig. (2-sided) Exact Sig. (1-sided) Pearson Chi-Square _2.236a 1 .135 Continuity Correction^b _1.559 ₁ _.212 Likelihood Ratio _2.250 ₁ _.134

Fisher's Exact Test _.149 _.106

Linear-by-Linear Association _2.202 ₁ _.138

N of Valid Cases^b ₆₆

a. 0 cells (,0%) have expected count less than 5. The minimum expected count is 15,03.

Risk Estimate

Value

95% Confidence Interval

Lower Upper

Odds Ratio for Kalsifikasi (ada kalsifikasi / tidak ada

kalsifikasi)

2.111 .788 5.654

For cohort Hasil_biopsi_PA =

Karsinoma ^1.430 ^.890 ^2.297

For cohort Hasil_biopsi_PA =

Non karsinoma ^.677 ^.400 ^1.148 N of Valid Cases ₆₆ Peningkatan_vaskularisasi * Hasil_biopsi_PA Crosstab Hasil_biopsi_PA Total Karsinoma Non karsinoma Peningkatan _vaskularisa si ada peningkatan vaskularisasi Count 27 23 50 % within Hasil_biopsi_PA 81.8% 71.9% 76.9% % of Total 41.5% 35.4% 76.9%

Tidak ada peningkatan vaskularisasi Count 6 9 15 % within Hasil_biopsi_PA 18.2% 28.1% 23.1% % of Total 9.2% 13.8% 23.1% Total Count 33 32 65 % within Hasil_biopsi_PA 100.0% 100.0% 100.0% % of Total 50.8% 49.2% 100.0%

70 Chi-Square Tests Value df Asymp. Sig. (2-sided) Exact Sig. (2-sided) Exact Sig. (1-sided) Pearson Chi-Square _.905a 1 .341 Continuity Correction^b _.431 ₁ _.511 Likelihood Ratio _.909 ₁ _.340

Fisher's Exact Test _.389 _.256

Linear-by-Linear Association _.891 ₁ _.345

N of Valid Cases^b ₆₅

a. 0 cells (,0%) have expected count less than 5. The minimum expected count is 7,38.

b. Computed only for a 2x2 table

Risk Estimate

Value

95% Confidence Interval

Lower Upper

Odds Ratio for

Peningkatan_vaskularisasi (ada peningkatan

vaskularisasi / Tidak ada peningkatan vaskularisasi)

1.761 .545 5.692

For cohort Hasil_biopsi_PA =

Karsinoma ^1.350 ^.690 ^2.640

For cohort Hasil_biopsi_PA =

Non karsinoma ^.767 ^.460 ^1.278

Crosstabs

[DataSet1] C:\Users\Testing\Documents\KTI yenny\kombinasi 1(kpsul+komp).s

Case Processing Summary Cases

Valid Missing Total N Percent N Percent N Percent usg * Hasil_biopsi_PA 20 95.2% 1 4.8% 21 100.0%

usg * Hasil_biopsi_PA Crosstabulation

Hasil_biopsi_PA Total Karsinoma Non karsinoma

usg karsinoma Count 1 0 1 Expected Count .4 .6 1.0 % within Hasil_biopsi_PA 11.1% .0% 5.0% % of Total 5.0% .0% 5.0% bukan karsinoma Count 8 11 19 Expected Count 8.6 10.4 19.0 % within Hasil_biopsi_PA 88.9% 100.0% 95.0% % of Total 40.0% 55.0% 95.0% Total Count 9 11 20 Expected Count 9.0 11.0 20.0 % within Hasil_biopsi_PA 100.0% 100.0% 100.0% % of Total 45.0% 55.0% 100.0%

Crosstabs

[DataSet1] C:\Users\Testing\Documents\KTI yenny\spss\kombinasi 2 (kapsul+

kalsifikasi).sav

Case Processing Summary Cases

Valid Missing Total N Percent N Percent N Percent USG * Hasil_biopsi_PA 51 92.7% 4 7.3% 55 100.0%

USG * Hasil_biopsi_PA Crosstabulation Count

Hasil_biopsi_PA

Total Karsinoma Non karsinoma

USG karsinoma 3 0 3 bukan karsinoma 24 24 48 Total 27 24 51

Crosstabs

[DataSet2] C:\Users\Testing\Documents\KTI yenny\komb 3 (kapsul+vask).sav

Case Processing Summary Cases

Valid Missing Total N Percent N Percent N Percent USG * Hasil_biopsi_PA 51 92.7% 4 7.3% 55 100.0%

USG * Hasil_biopsi_PA Crosstabulation Count

Hasil_biopsi_PA

Total Karsinoma Non karsinoma

USG karsinoma 3 0 3 bukan karsinoma 22 26 48 Total 25 26 51

Crosstabs

[DataSet1] C:\Users\Testing\Documents\KTI yenny\spss\komb5 (komp+vas).sav

Case Processing Summary Cases

Valid Missing Total N Percent N Percent N Percent USG * Hasil_biopsi_PA 24 92.3% 2 7.7% 26 100.0%

USG * Hasil_biopsi_PA Crosstabulation Count

Hasil_biopsi_PA

Total Karsinoma Non karsinoma

USG karsinoma 4 3 7 bukan karsinoma 7 10 17 Total 11 13 24

Crosstabs

[DataSet1] C:\Users\Testing\Documents\KTI yenny\spss\komb6 (kals+vask).sa

Case Processing Summary Cases

Valid Missing Total N Percent N Percent N Percent USG * Hasil_biopsi_PA 60 89.6% 7 10.4% 67 100.0%

USG * Hasil_biopsi_PA Crosstabulation Count

Hasil_biopsi_PA

Total Karsinoma Non karsinoma

USG karsinoma 12 8 20 bukan karsinoma 17 23 40 Total 29 31 60

Crosstabs

[DataSet2] C:\Users\Testing\Documents\KTI yenny\spss\komb7 (kapsul+komp+k

als).sav

Case Processing Summary Cases

Valid Missing Total N Percent N Percent N Percent USG * Hasil_biopsi_PA 20 95.2% 1 4.8% 21 100.0%

USG * Hasil_biopsi_PA Crosstabulation Count

Hasil_biopsi_PA

Total Karsinoma Non karsinoma

USG karsinoma 1 0 1 bukan karsinoma 8 11 19 Total 9 11 20

Crosstabs

[DataSet3] C:\Users\Testing\Documents\KTI yenny\spss\komb8 (kapsul+komp+v

as).sav

Case Processing Summary Cases

Valid Missing Total N Percent N Percent N Percent USG * Hasil_biopsi_PA 19 95.0% 1 5.0% 20 100.0%

USG * Hasil_biopsi_PA Crosstabulation Count

Hasil_biopsi_PA

Total Karsinoma Non karsinoma

USG karsinoma 1 0 1 bukan karsinoma 7 11 18 Total 8 11 19

Crosstabs

[DataSet4] C:\Users\Testing\Documents\KTI yenny\spss\komb9 (kapsul+kals+v

as).sav

Case Processing Summary Cases

Valid Missing Total N Percent N Percent N Percent USG * Hasil_biopsi_PA 48 92.3% 4 7.7% 52 100.0%

USG * Hasil_biopsi_PA Crosstabulation Count

Hasil_biopsi_PA

Total Karsinoma Non karsinoma

USG karsinoma 3 0 3 bukan karsinoma 20 25 45 Total 23 25 48

Crosstabs

[DataSet5] C:\Users\Testing\Documents\KTI yenny\spss\komb10 (komp+kals+va

s).sav

Case Processing Summary Cases

Valid Missing Total N Percent N Percent N Percent USG * Hasil_biopsi_PA 23 92.0% 2 8.0% 25 100.0%

USG * Hasil_biopsi_PA Crosstabulation Count

Hasil_biopsi_PA

Total Karsinoma Non karsinoma

USG karsinoma 2 2 4 bukan karsinoma 8 11 19 Total 10 13 23

Crosstabs

[DataSet6] C:\Users\Testing\Documents\KTI yenny\spss\komb11 (kaps+komp+ka

ls+vas).sav

Case Processing Summary Cases

Valid Missing Total N Percent N Percent N Percent USG * Hasil_biopsi_PA 20 95.2% 1 4.8% 21 100.0%

USG * Hasil_biopsi_PA Crosstabulation Count

Hasil_biopsi_PA

Total Karsinoma Non karsinoma

USG karsinoma 1 0 1 bukan karsinoma 7 12 19 Total 8 12 20

BIODATA PENELITI

Identitas

Nama : Yenny Kartika Gozali

NIM : G2A008198

Tempat/tanggal lahir : Semarang,, 9 Januari 1991

Jenis kelamin :Wanita

Alamat : Kepodang Barat VII no. 117 Semarang

Nomor telpon : -

Nomor HP : 085640700567

e-mail :cikyen_oye@yahoo.com

Riwayat Pendidikan Formal

1. SD : SD Karang Rejo 01 Lulus tahun : 2002

2. SMP :SMP Negeri 21 Semarang Lulus tahun : 2005

3. SMA :SMA Negeri 3 Semarang Lulus tahun : 2008

4. FK UNDIP : Masuk tahun: 2008

Keanggotaan Organisasi : - Pengalaman Penelitian : -

Pengalaman publikasi tulisan ilmiah : - Pengalam presentasi karya ilmiah : - Pengalaman mengikuti lomba karya ilmiah : -

Dalam dokumen Yenny K G G2A008198 Lap (Halaman 62-91)